|
1
|
Doucet M, Rochette L and Hamel D:
Incidence, prevalence, and mortality trends in chronic obstructive
pulmonary disease over 2001 to 2011: A public health point of view
of the burden. Can Respir J. 2016:75182872016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pauwels RA and Rabe KF: Burden and
clinical features of chronic obstructive pulmonary disease (COPD).
Lancet. 364:613–620. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bao H, Fang L and Wang L: Prevalence of
chronic obstructive pulmonary disease among community population
aged ≥40 in China: A meta-analysis on studies published between
1990 and 2014. Zhonghua Liu Xing Bing Xue Za Zhi. 37:119–124.
2016.(In Chinese). PubMed/NCBI
|
|
4
|
Zhong N, Wang C, Yao W, Chen P, Kang J,
Huang S, Chen B, Wang C, Ni D, Zhou Y, et al: Prevalence of chronic
obstructive pulmonary disease in China: A large, population-based
survey. Am J Respir Crit Care Med. 176:753–760. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vestbo J, Hurd SS, Agusti AG, Jones PW,
Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ,
Nishimura M, et al: Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang Y, Xu P, Gu C, Fu XJ, Yu WR and Yao
M: Ulinastatin improves pulmonary function in severe burn-induced
acute lung injury by attenuating inflammatory response. J Trauma.
71:1297–1304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li W, Qiu X, Jiang H, Zhi Y, Fu J and Liu
J: Ulinastatin inhibits the inflammation of LPS-induced acute lung
injury in mice via regulation of AMPK/NF-κB pathway. Int
Immunopharmacol. 29:560–567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang SY, Li ZJ, Wang X, Li WF and Lin ZF:
Effect of ulinastatin on HMGB1 expression in rats with acute lung
injury induced by sepsis. Genet Mol Res. 14:4344–4353. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang Y, Qiu X, Zhou G, Liu Z, Chang N and
Jia C: Early effects of ulinastatin by aerosol inhalation on
rabbits with lipopolysaccharide-induced acute lung injury. Zhonghua
Shao Shang Za Zhi. 30:203–207. 2014.(In Chinese). PubMed/NCBI
|
|
10
|
Wang N, Liu X, Zheng X, Cao H, Wei G, Zhu
Y, Fan S, Zhou H and Zheng J: Ulinastatin is a novel candidate drug
for sepsis and secondary acute lung injury, evidence from an
optimized CLP rat model. Int Immunopharmacol. 17:799–807. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dange RB, Agarwal D, Teruyama R and
Francis J: Toll-like receptor 4 inhibition within the
paraventricular nucleus attenuates blood pressure and inflammatory
response in a genetic model of hypertension. J Neuroinflammation.
12:312015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang H, Bloom O, Zhang M, Vishnubhakat JM,
Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et
al: HMG-1 as a late mediator of endotoxin lethality in mice.
Science. 285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Hu C, Yao Y and Yang H: Effects of
ulinastatin on immune function of spleen in severely burned rats
and its mechanism. Zhonghua Shao Shang Za Zhi. 32:266–271. 2016.(In
Chinese). PubMed/NCBI
|
|
14
|
Tong Y, Tang Z, Yang T, Yang Y, Yang L,
Shen W and Chen W: Ulinastatin preconditioning attenuates
inflammatory reaction of hepatic ischemia reperfusion injury in
rats via high mobility group box 1(HMGB1) inhibition. Int J Med
Sci. 11:337–343. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gangemi S, Casciaro M, Trapani G,
Quartuccio S, Navarra M, Pioggia G and Imbalzano E: Association
between HMGB1 and COPD: A systematic review. Mediators Inflamm.
2015:1649132015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Huang XJ, Yu N, Xie Y, Zhang K,
Wen F, Liu H and Di Q: HMGB1 contributes to the expression of
P-glycoprotein in mouse epileptic brain through toll-like receptor
4 and receptor for advanced glycation end products. PLoS One.
10:e1409182015.
|
|
17
|
Li G, Wu X, Yang L, He Y, Liu Y, Jin X and
Yuan H: TLR4-mediated NF-κB signaling pathway mediates
HMGB1-induced pancreatic injury in mice with severe acute
pancreatitis. Int J Mol Med. 37:99–107. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng Y, Wang D, Wang B, Li H, Xiong J, Xu
S, Chen Q, Tao K, Yang X, Zhu Y and He S: HMGB1 translocation and
release mediate cigarette smoke-induced pulmonary inflammation in
mice through a TLR4/MyD88-dependent signaling pathway. Mol Biol
Cell. 28:201–209. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lai CH, Wang KC, Lee FT, Tsai HW, Ma CY,
Cheng TL, Chang BI, Yang YJ, Shi GY and Wu HL: Toll-like receptor 4
is essential in the development of abdominal aortic aneurysm. PLoS
One. 11:e1465652016.
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reséndiz-Hernández JM and Falfán-Valencia
R: Genetic polymorphisms and their involvement in the regulation of
the inflammatory response in asthma and COPD. Adv Clin Exp Med.
27:125–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huckle AW, Fairclough LC and Todd I:
Prophylactic antibiotic use in COPD and the potential
anti-inflammatory activities of antibiotics. Respir Care.
63:609–619. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamasaki K and Eeden S: Lung macrophage
phenotypes and functional responses: Role in the pathogenesis of
COPD. Int J Mol Sci. 19:pii: E582. 2018. View Article : Google Scholar
|
|
24
|
Wan X, Xie X, Gendoo Y, Chen X, Ji X and
Cao C: Ulinastatin administration is associated with a lower
incidence of acute kidney injury after cardiac surgery: A
propensity score matched study. Crit Care. 20:422016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang C, Wang Y, Fu W, Zhang W, Wang T and
Qin H: A meta-analysis on the effect of ulinastatin on serum levels
of C-reactive protein, interleukin 6, and tumor necrosis factor
alpha in Asian patients with acute pancreatitis. Genet Test Mol
Biomarkers. 20:118–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun R, Li Y, Chen W, Zhang F and Li T:
Total ginsenosides synergize with ulinastatin against septic acute
lung injury and acute respiratory distress syndrome. Int J Clin Exp
Pathol. 8:7385–7390. 2015.PubMed/NCBI
|
|
27
|
Yanagisawa S and Ichinose M: Definition
and diagnosis of asthma-COPD overlap (ACO). Allergol Int.
67:172–178. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Twigg MJ and Wright DJ: Community pharmacy
COPD services: What do researchers and policy makers need to know?
Integr Pharm Res Pract. 6:53–59. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ko HK, Hsu WH, Hsieh CC, Lien TC, Lee TS
and Kou YR: High expression of high-mobility group box 1 in the
blood and lungs is associated with the development of chronic
obstructive pulmonary disease in smokers. Respirology. 19:253–261.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kanazawa H, Tochino Y, Asai K, Ichimaru Y,
Watanabe T and Hirata K: Validity of HMGB1 measurement in
epithelial lining fluid in patients with COPD. Eur J Clin Invest.
42:419–426. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li H, Yang T, Li FY, Ning Q and Sun ZM:
TLR4 overexpression inhibits endothelial PAS domain-containing
protein 1 expression in the lower respiratory tract of patients
with chronic COPD. Cell Physiol Biochem. 39:685–692. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang S, Xiong L, Deng X, Ren W, Zhu C, Li
C and Zhou Q: Effects of simvastatin on airway inflammation and
airway mucus hypersecretion in rats with chronic obstructive
pulmonary disease. Zhonghua Yi Xue Za Zhi. 95:1726–1730. 2015.(In
Chinese). PubMed/NCBI
|
|
33
|
Zeng X, Liu X, Bao H, Zhang Y, Wang X, Shi
K and Pang Q: Effects of sulforaphane on Toll-like receptor
4/myeloid differentiation factor 88 pathway of monocyte-derived
macrophages from patients with chronic obstructive pulmonary
disease. Zhonghua Jie He He Hu Xi Za Zhi. 37:250–254. 2014.(In
Chinese). PubMed/NCBI
|
|
34
|
Wang J, Wu A and Wu Y: Endothelial
glycocalyx layer: A possible therapeutic target for acute lung
injury during lung resection. Biomed Res Int. 2017:59696572017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu W and Chai JK: Influences of
ulinastatin on acute lung injury and time phase changes of
coagulation parameters in rats with burn-blast combined injuries.
Zhonghua Shao Shang Za Zhi. 34:32–39. 2018.(In Chinese). PubMed/NCBI
|
